|Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making|
F Jibril, S Sharaby, A Mohamed, KJ Wilby
The Canadian journal of hospital pharmacy 68 (3), 238, 2015
|Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration|
RF Eyler, AM Vilay, AM Nader, M Heung, M Pleva, KM Sowinski, ...
Antimicrobial agents and chemotherapy 58 (3), 1320-1326, 2014
|Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis|
NM Mostafa, AM Nader, P Noertersheuser, M Okun, WM Awni
Journal of the European Academy of Dermatology and Venereology 31 (3), 490-497, 2017
|Suitability of digoxin as a P‐glycoprotein probe: Implications of other transporters on sensitivity and specificity|
AM Nader, DR Foster
The Journal of Clinical Pharmacology 54 (1), 3-13, 2014
|A semi‐mechanistic metabolism model of CYP3A substrates in pregnancy: predicting changes in midazolam and nifedipine pharmacokinetics|
SK Quinney, AN Mohamed, MF Hebert, DM Haas, S Clark, JG Umans, ...
CPT: pharmacometrics & systems pharmacology 1 (9), 1-9, 2012
|Population pharmacokinetics of intravenous methotrexate in patients with hematological malignancies: utilization of routine clinical monitoring parameters|
A Nader, N Zahran, A Alshammaa, H Altaweel, N Kassem, KJ Wilby
European journal of drug metabolism and pharmacokinetics 42 (2), 221-228, 2017
|Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis|
BS Decker, AN Mohamed, M Chambers, MA Kraus, SM Moe, ...
American journal of nephrology 36 (2), 144-150, 2012
|Population pharmacokinetics and immunogenicity of adalimumab in adult patients with moderate-to-severe hidradenitis suppurativa|
A Nader, D Beck, P Noertersheuser, D Williams, N Mostafa
Clinical pharmacokinetics 56 (9), 1091-1102, 2017
|Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine|
AM Nader, SK Quinney, HM Fadda, DR Foster
The AAPS Journal, 1-8, 2016
|Population pharmacokinetics of elagolix in healthy women and women with endometriosis|
I Winzenborg, A Nader, AR Polepally, M Liu, J Degner, CE Klein, ...
Clinical pharmacokinetics 57 (10), 1295-1306, 2018
|Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal …|
AN Mohamed, AM Abdelhady, D Spencer, KM Sowinski, JE Tisdale, ...
American Journal of Kidney Diseases 61 (6), 1046-1048, 2013
|Identification of HLA-DRB1 association to adalimumab immunogenicity|
M Liu, J Degner, JW Davis, KB Idler, A Nader, NM Mostafa, JF Waring
PloS one 13 (4), e0195325, 2018
|Clinical pharmacology of elagolix: an oral gonadotropin-releasing hormone receptor antagonist for endometriosis|
M Shebley, AR Polepally, A Nader, JW Ng, I Winzenborg, CE Klein, ...
Clinical pharmacokinetics, 1-13, 2019
|Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of …|
A Nader, S Stodtmann, A Friedel, MEF Mohamed, AA Othman
The Journal of Clinical Pharmacology, 2019
|FRI0138 EXPOSURE-RESPONSE ANALYSES OF UPADACITINIB EFFICACY AND SAFETY IN RHEUMATOID ARTHRITIS–ANALYSES OF PHASE 2 AND 3 STUDIES|
ME Mohamed, A Nader, I Winzenborg, E Doelger, P Noertersheuser, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 739-740, 2019
|A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patient.|
AL Myers, JD Kawedia, A Nader, JR Westin, BR Shank
Journal of clinical pharmacy and therapeutics, 2019
|Combined Efficacy and Safety Modeling and Simulation Approach to Inform Drug Development Decisions for an Oral Gonadotropin-releasing Hormone (GnRH) Receptor Antagonist|
A Nader, I Winzenborg, A Suleiman, A Polepally, J Ng, M Shebley, ...
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S4-S4, 2018
|Long‐term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis|
R Gniadecki, CL Leonardi, KB Gordon, Y Gu, Z Geng, A Nader, ...
Journal of the European Academy of Dermatology and Venereology 32 (8), 1297-1304, 2018
|COMPARTMENTAL PHARMACOKINETICS (PK) OF IMMEDIATE RELEASE NIFEDIPINE (NIF) IN PREGNANCY: VARIABILITY IN ABSORPTION.: PIII-109|
A Nader, S Caritis, M Hebert, S Clark, D Flockhart, S Quinney
Clinical Pharmacology & Therapeutics 91, 2012
|Exposure‐Response Analyses of Upadacitinib Efficacy and Safety in Phase 2 and 3 Studies to Support Benefit‐Risk Assessment in Rheumatoid Arthritis|
A Nader, MEF Mohamed, I Winzenborg, E Doelger, P Noertersheuser, ...
Clinical Pharmacology & Therapeutics, 2019